Pharma Journalist -

Shionogi & Co., Ltd. announced that, after completing a Priority Review, the U.S. Food and Drug Administration (FDA) has approved Mulpleta (lusutrombopag), a once-daily, orally…
Read More...

Abdi Ibrahim has carefully selected rfxcel to implement and support new compliance management and serialisation processing software to ensure full compliance with current and future…
Read More...

Torque, an immuno-oncology company developing first-in-class Deep Primed T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today a…
Read More...

Forge Therapeutics, Inc. (Forge), a biotechnology company developing novel medicines targeting metalloenzymes, announced that, based on achievement of technical milestones, it has…
Read More...

Nutriband Inc announced the formal completion of the acquisition of Atlanta-based 4P Therapeutics Inc. Pursuant to the previously announced acquisition agreement, on Aug 1, 2018,…
Read More...

Players throughout the pharmaceutical supply chain are experiencing growing pressure to gain accreditation for handling the high-value, temperature-sensitive cargo, as having a…
Read More...

SMi are delighted to have interviewed Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals regarding his thoughts and experiences within the ophthalmology space.…
Read More...

The lengthening shadow of increase in health spending in the coming years is sharpening the minds of legislators, regulators and payers alike. The growing time-to-market, the rising…
Read More...

Puma Biotechnology announced that Health Canada has accepted for review the Company’s New Drug Submission (NDS) for the medicinal product NERLYNX (neratinib) for the extended adjuvant…
Read More...

LEO Pharma and Bayer announced that LEO Pharma has entered into a definitive agreement to buy Bayer’s global prescription dermatology unit. The portfolio to be acquired includes branded…
Read More...